CT and MRI are first-line imaging modalities used to evaluate incidental adrenal lesions. CT has the advantages of being accessible, quick, and relatively inexpensive, particularly noncontrast CT. If an adrenal lesion has a density of 10 HU or less, a diagnosis of lipid-rich adenoma can be made confi dently with noncontrast CT. 2 If the density of the adrenal lesion is above 10 HU, the addition of multiphase, contrast enhanced CT can be helpful to distinguish between adrenal adenomas and nonadenomas using absolute and relative contrast washout percentages. These are calculated from HU obtained during standard portal venous and 15-minute delay acquisitions, as follows:
Adrenal lesions are a relatively common incidental fi nding and are estimated to be present in 4 .4% of all abdominal CT scans. 1 
The detection of an adrenal lesion often necessitates a thorough clinical evaluation that frequently requires a comprehensive patient history, biochemical studies, and radiologic studies such as dedicated adrenal protocol CT or MRI. The primary goal of additional radiologic studies is to differentiate benign from malignant adrenal lesions. It is, therefore, important for the radiologist to be familiar with a variety of benign and malignant adrenal lesions and to recognize distinctive imaging characteristics that can help make this distinction. This article reviews typical and useful imaging features of more commonly encountered benign and malignant adrenal lesions.

Evaluation With CT and MRI
CT and MRI are first-line imaging modalities used to evaluate incidental adrenal lesions. CT has the advantages of being accessible, quick, and relatively inexpensive, particularly noncontrast CT. If an adrenal lesion has a density of 10 HU or less, a diagnosis of lipid-rich adenoma can be made confi dently with noncontrast CT. 2 If the density of the adrenal lesion is above 10 HU, the addition of multiphase, contrast enhanced CT can be helpful to distinguish between adrenal adenomas and nonadenomas using absolute and relative contrast washout percentages. These are calculated from HU obtained during standard portal venous and 15-minute delay acquisitions, as follows:
Relative Percentage Washout = Enhanced CT (HU) − Delayed CT (HU) Enhanced CT (HU) × 100
An absolute percentage washout (APW) of more than 60% and a relative percentage washout (RPW) of more than 40% are typical of an adrenal adenoma. 3 In-and opposed-phase chemical shift imaging on MRI also can be useful to diagnose adrenal adenomas containing various amounts of microscopic intracellular fat. An adrenal adenoma can be diagnosed when there is loss of signal on T1 out-of-phase MR images compared with T1 in-phase MR images because of the presence of microscopic fat.
If quantitative measurement is desired, an adrenal signal intensity index can be calculated as follows 4 : Adrenal Signal Intensity Index = Sl on In-Phase -Sl on Opposed-Phase Sl on In-Phase × 100
An adrenal signal intensity index greater than 16.5% is typical for a lipid-rich adrenal adenoma. 4 CT and MRI also are excellent imaging modalities to detect the presence of macroscopic fat, which is a distinguishing feature of adrenal myelolipomas. Other imaging characteristics that are not specifi c but can aid in assessment of incidental adrenal lesions include size, changes in size, enhance ment, and morphology. CT and MRI analyses, in conjunction with a thorough clinical history that includes a history of nonadrenal malignancy, clinical biomarkers, and symptoms, also are important for the evaluation of incidental adrenal lesions.
Benign Adrenal Lesions
Adrenal Adenomas. Adrenal adenomas comprise the majority of incidentally detected adrenal lesions. Two key characteristics of adrenal adenomas that aid in radiologic diagnosis include the presence of intracellular fat and rapid washout of IV contrast medium. Lipid-rich adrenal adenomas contain various amounts of intracellular fat, which can be evaluated using noncontrast CT and chemical shift MRI as described in the previous section. The majority of adrenal adenomas are lipid rich and can be characterized as lipid-rich adenomas with noncontrast CT or chemical shift MR imaging (Figures 1 and 2 ). Some adrenal adenomas contain inadequate amounts of intracellular lipid and are indeterminate on noncontrast CT and chemical shift imaging; these adrenal lesions are considered lipid-poor adrenal adenomas, and they represent approximately 10% to 40% of all adrenal adenomas. 3 Rapid washout of IV contrast medium is a reasonably sensitive and specifi c way to diagnose an adrenal adenoma.
Other, less-specifi c imaging features of adrenal adenomas include smooth, well-defi ned margins; homogeneous attenuation; and relatively small size. 3 After the administration of contrast medium, enhancement is typically homogeneous and may demonstrate an arterial blush. 5 It is important to remember that adrenal adenomas may hemorrhage, which can alter the attenuation characteristics. Compared with other adrenal lesions such as metastasis, pheochromocytoma, and adrenocortical carcinoma, adenomas are typically smaller, with an average size of 2 to 2.5 cm; the largest adenomas measure approximately 3 cm. 3 Biochemical analysis is required to distinguish between functional and nonfunctional adrenal adenomas. Radiologic studies are unable to distinguish between them; however, contralateral adrenal gland atrophy may suggest the presence of a functioning lesion. 3 Fortunately, the vast majority of adrenal adenomas are hormonally nonfunctioning.
Adrenal Myelolipomas. Adrenal myelolipomas are benign tumors that contain macroscopic fat and hematopoietic tissue. The presence of macroscopic fat is their key distinguishing feature on CT and MRI (Figures 3 and 4) . The majority of adrenal myelolipomas have a pseudocapsule and contain various amounts of soft tissue and macroscopic fat. Myelolipomas are typically asymptomatic; however, they may become clinically apparent if they undergo hemorrhage or are symptomatic because of mass effect. Calcifi cations within them also may be present. A potential pitfall to recognize is that in rare cases, other adrenal tumors have been reported to contain macroscopic fat, including adrenal adenomas, adrenocortical carcinoma, pheochromocytomas, and adrenal metastases. 3 Adrenal Hemorrhage. Adrenal hemorrhage has a variety of etiologies but often is associated with an acute physiologic stress such as shock, sepsis, and surgery; and anticoagulation and hemorrhagic diathesis. Neonates are at a relatively higher risk of adrenal hemorrhage compared with older children and adults. Adrenal hemorrhage can have a variable imaging appearance depending on the age of the hemorrhage and size of the hemorrhage. Acute and subacute hemorrhage will appear hyperattenuated on CT with progressive decrease in attenuation over time as the hemorrhage evolves ( Figure 5 ). Chronic hematomas may develop calcifi cations. On MRI, adrenal hemorrhage will have variable T1 and T2 signal depending on the age of the hematoma. Over time, a T1-and T2-hypointense rim may develop around the hemorrhage because of the presence of hemosiderin ( Figure 6 ). The size of the adrenal hemorrhage should decrease over time and demonstrate no postcontrast enhancement. Bilateral adrenal hemorrhage is caused more typically by systemic etiologies, such as sepsis and shock; whereas unilateral adrenal hemorrhage is caused more frequently by blunt trauma. Posttraumatic and neonatal stress-related adrenal hemorrhage more often involves the right adrenal gland, which has been attributed to the compression of the right adrenal gland between the The majority of pheochromocytomas are benign; however, approximately 10% of pheochromocytomas are malignant. Although both benign and malignant pheochromocytomas typically follow nonadenoma washout characteristics (APW <60% and RPW <40%), it is important to recognize that pheochromocytomas may have washout characteristics that can mimic those of a benign adrenal adenoma. 6 Pheochromocytomas may be associated with familial syndromes such as multiple endocrine neoplasia 2, neurofibromatosis type 1, and von Hippel-Lindau disease. The clinical and familial history and coexisting lesions in other organs (e.g., thyroid nodules, renal and pancreatic cysts, enlarged parathyroid glands, and central nervous system hemangioblastomas) may offer clues to this diagnosis.
Adrenal Metastasis. The imaging features of adrenal metastases are nonspecifi c. Adrenal metastases may be bilateral or unilateral. Some adrenal metastases may have internal hemorrhage or necrosis (Figure 9 ). Typically, adrenal metastases will have slower washout compared with adrenal adenomas on delayed contrast imaging (APW <60% and RPW <40%). However, it is important to recognize that hypervascular metastases, such as renal cell carcinoma and hepatocellular carcinoma, may have similar washout to adrenal adenomas, particularly lipid-poor adrenal adenomas, on delayed contrast imaging. 7 Other highly suspicious imagining features of adrenal metastasis include large lesions (>4 cm) or interval growth between imaging studies. An adrenal lesion in a patient older than 60 years or with a personal history of a malignancy should be scrutinized for metastasis.
Adrenocortical Carcinoma. Similar to adrenal metastases, the imaging features of adrenocortical carcinoma are nonspecifi c. Typically, adrenocortical carcinoma will be a large adrenal mass with heterogeneous enhancement (Figure 10) . Hormonally functional adrenocortical carcinoma may present at smaller sizes because of clinically apparent symptoms such as liver and the right kidney. It is important to exclude an underlying adrenal lesion, such as an adenoma or myelolipoma, as the source of adrenal hemorrhage.
Malignant Adrenal Lesions
Adrenal Pheochromocytoma. Pheochromocytomas are catecholamine (e.g., epinephrine and norepinephrine)-secreting tumors. Patients may have subclinical symptoms or present with symptoms of catecholamine excess including paroxysmal hypertension, diaphoresis, tachycardia, fl ushing, and headache. Classically, pheochromocytomas appear hyperintense on T2-weighted MR images and can have internal areas of cystic necrosis (Figure 7 ). Pheochromocytomas are vascular tumors and typically avidly enhance after the administration of contrast medium. On T1-and T2-weighted MR images, prominent vessels can create low-signal fl ow voids against a hyperintense background, resulting in a classically described "salt and pepper" appearance ( Figure 8 ). Lesion size is an important but imperfect predictor of adrenal malignancy. Smaller lesions tend to be benign, whereas larger lesions (>4 cm) are more likely to be malignant. Therefore, adrenal lesions larger than 4 cm typically are considered for resection. 8 A patient with no history of malignancy and an adrenal mass that is smaller than 4 cm with benign features generally is monitored. 9 The frequency of surveillance is variable depending on which organization's consensus statement is followed. The American Association of Clinical Endocrinologists recommends that patients with an adrenal incidentaloma not meeting criteria for surgical resection should have radiologic reevaluation at 3 to 6 months and then annually for up to 1 to 2 years. 8 The American College of Radiology recommends a 12-month follow-up to confi rm stability if there are no prior studies for comparison. 10 It should be noted that more long-term biochemical follow-up may be necessary to evaluate autonomous function. If an adrenal myelolipoma or a simple adrenal cyst can be diagnosed, there is usually no additional follow-up; however, surgical evaluation may be necessary if the lesion is symptomatic or large. If a lesion is indeterminate or has suspicious characteristics, including but not limited to large size, increase in size, heterogeneous enhancement, or necrosis, further evaluation with biopsy or surgery may be necessary. It is important for the radiologist to recognize and consider typical imaging characteristics of a pheochromocytoma because hemorrhage and hypertensive crisis have been reported as biopsy complications.
Conclusion
Adrenal lesions are a relatively common fi nding in abdominal imaging, and the majority of adrenal lesions are benign. Familiarity with the imaging features of common benign and malignant adrenal lesions is important to help guide patient management and follow-up. This CME activity emphasizes distinguishing imaging features of the more common benign and malignant adrenal lesions that radiologists should recognize.
Cushing syndrome, virilization, or feminization. Adrenocortical carcinoma may have areas of necrosis, and up to 33% will have calcifi cations. 3 As mentioned previously, it is important to recognize that in rare cases, adrenocortical carcinoma may contain macroscopic or microscopic fat, and it should not be mistaken for an adrenal myelolipoma or adenoma, respectively. Invasion of an adrenocortical carcinoma into the inferior vena cava is an important and well-known complication to observe.
Patient Management
Key questions that guide patient management in the evaluation of an adrenal lesion include: what is the size of the lesion; and can the lesion be characterized as benign or malignant? Figure 9 . Coronal, contrast enhanced CT scan demonstrates a large, partially necrotic, right adrenal metastasis with heterogeneous enhancement in a patient with hepatocellular carcinoma. Figure 10 . Axial, contrast enhanced CT scan shows a large (7.7 cm), right adrenocortical carcinoma with heterogeneous postcontrast enhancement.
